MAYZENT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Siponimod.
Product ID | 0078-1014_7bc3f410-9309-4045-8eab-2dc16c0173fd |
NDC | 0078-1014 |
Product Type | Human Prescription Drug |
Proprietary Name | MAYZENT |
Generic Name | Siponimod |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-03-26 |
Marketing Category | NDA / |
Application Number | NDA209884 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | SIPONIMOD |
Active Ingredient Strength | 1 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0979 | MAYZENT | siponimod |
0078-0986 | MAYZENT | siponimod |
0078-1014 | MAYZENT | siponimod |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MAYZENT 87816240 5846370 Live/Registered |
Novartis AG 2018-03-01 |
MAYZENT 79261592 not registered Live/Pending |
NOVARTIS AG 2019-05-03 |
MAYZENT 79156316 4714545 Live/Registered |
Novartis AG 2014-09-12 |
MAYZENT 79043338 3441076 Dead/Cancelled |
Novartis AG 2007-08-31 |